Sanofi to acquire Translate Bio for $3.2B to boost mRNA technology
Sanofi to acquire Translate Bio for $3.2B to boost mRNA technology
SeekingAlpha
0 shares
1 views
You might like
Related news coverage
US stocks finish in positive territory thanks to strong earnings
Proactive Investors
4.10pm: US stocks finish strongly as investors sigh with relief at a slew of positive earnings Wall Street ended the day flush in..
-
Sanofi makes $3.2B bet on mRNA by acquiring partner Translate Bio
bizjournals
-
US stocks higher midday as strong earnings offset Delta variant concerns
Proactive Investors
-
US stocks beat early retreat as investors weigh up earnings, more M&A action
Proactive Investors
-
Translate Bio soars 30% after Sanofi agrees to buy the mRNA company for $3.2 billion
Business Insider